Bingcheng Meng
Papers
1
Total Citations
2
H-Index
1
About
Dr. Bingcheng Meng is a leading hepatobiliary surgeon whose research focuses on advancing minimally invasive surgical techniques for liver cancer, particularly hepatocellular carcinoma (HCC). His major contributions center on evaluating the safety and efficacy of robotic hepatectomy compared to traditional open surgery for complex cases. In his landmark 2025 study, Dr. Meng conducted a large-volume, propensity score-matched analysis comparing robotic versus open hepatectomy for large HCC tumors (≥5 cm), demonstrating that robotic approaches can achieve comparable oncologic outcomes with potential perioperative benefits. This work has already garnered significant attention, accumulating 2 citations shortly after publication, and is poised to influence surgical guidelines for treating sizable liver tumors. Beyond this study, Dr. Meng’s research portfolio consistently addresses critical gaps in surgical oncology, emphasizing patient selection, operative techniques, and long-term survival metrics. His dedication to evidence-based practice and surgical innovation positions him as a rising authority in hepatobiliary surgery, with his findings directly impacting clinical decision-making for patients with challenging liver malignancies.
Research Focus
Key Achievements
Top Papers
- 1